Literature DB >> 18578363

Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese.

Naomi Masunari1, Saeko Fujiwara, Yoshihiro Nakata, Kyoji Furukawa, Fumiyoshi Kasagi.   

Abstract

We investigated the effects of several frequently described medication regimens on annual percentage change in bone mineral density (BMD). A longitudinal cohort study (a retrospective analysis) was conducted. Subjects in the Adult Health Study (a prospective cohort study begun in 1958) have been followed through biennial medical examinations in Hiroshima, Japan. Participants were 2,111 subjects (67% women; aged 47-95 years) who were undergoing biennial health examinations from 1994 to 2000. The subjects were examined for the effect of certain drugs on bone mineral change during baseline and one follow-up (4 year later) measurements. Mean annual percentage change in BMD at the femoral neck was -0.38% for men, and -1.14% for women. After adjustment for sex, age, change of weight, alcohol consumption, and smoking status, annual percentage change in BMD decreased by 0.61% among individuals taking angiotensin converting enzyme (ACE) inhibitors continuously in comparison with individuals who had not taken them (p = 0.002): also decreased 0.40% among individuals taking benzodiazepines (BZDs) continuously (p = 0.034). Our results suggest that careful consideration should be given to the use of ACE inhibitors and BZDs in a cohort of Japanese elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18578363

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  16 in total

Review 1.  Benefits and pitfalls of cardiovascular medication in seniors.

Authors:  Hana Matejovska Kubesova; Pavel Weber; Hana Meluzinova; Katarina Bielakova; Jan Matejovsky
Journal:  Wien Klin Wochenschr       Date:  2013-07-12       Impact factor: 1.704

2.  Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men.

Authors:  Nahid Rianon; Catherine G Ambrose; Hannah Pervin; Melissa Garcia; Scherezade K Mama; Ann V Schwartz; Brendan Lee; Tamara Harris
Journal:  Arch Osteoporos       Date:  2017-10-28       Impact factor: 2.617

3.  The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.

Authors:  L D Carbone; S Vasan; R L Prentice; G Harshfield; B Haring; J A Cauley; K C Johnson
Journal:  Osteoporos Int       Date:  2019-06-17       Impact factor: 4.507

4.  Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.

Authors:  Y Zhang; L Wang; Y Song; X Zhao; M S Wong; W Zhang
Journal:  Osteoporos Int       Date:  2015-10-06       Impact factor: 4.507

5.  Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts.

Authors:  Yu Yu Liu; Wei Min Yao; Tie Wu; Bi Lian Xu; Fang Chen; Liao Cui
Journal:  J Bone Miner Metab       Date:  2010-08-06       Impact factor: 2.626

6.  Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?

Authors:  T Kwok; J Leung; Y F Zhang; D Bauer; K E Ensrud; E Barrett-Connor; P C Leung
Journal:  Osteoporos Int       Date:  2011-11-12       Impact factor: 4.507

7.  ACE inhibitor use was associated with lower serum dehydroepiandrosterone concentrations in older men.

Authors:  T Kwok; C Ohlsson; L Vandenput; N Tang; Y F Zhang; B Tomlinson; P C Leung
Journal:  Clin Chim Acta       Date:  2010-04-24       Impact factor: 3.786

8.  ACE inhibitors and the risk of fractures: a meta-analysis of observational studies.

Authors:  Yan-Zhen Cheng; Zhen-Zi Huang; Ze-Feng Shen; Hai-Yang Wu; Jia-Xin Peng; Mary Miu Yee Waye; Shi-Tao Rao; Li Yang
Journal:  Endocrine       Date:  2016-12-19       Impact factor: 3.633

9.  The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese.

Authors:  Ya-Feng Zhang; Ling Qin; Ping-Chung Leung; Timothy C Y Kwok
Journal:  J Bone Miner Metab       Date:  2012-06-29       Impact factor: 2.626

10.  Human liver rate-limiting enzymes influence metabolic flux via branch points and inhibitors.

Authors:  Min Zhao; Hong Qu
Journal:  BMC Genomics       Date:  2009-12-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.